IA2030 Scorecard
—Global
Type to select a Country
2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | |
---|---|---|---|---|
Decreased share | 32.1% | 21.4% | 33.9% | 39.3% |
Stable share | 33.9% | 30.4% | 30.4% | 26.8% |
Increased share | 33.9% | 48.2% | 35.7% | 33.9% |
Step 1) Retreive relevant data from WHO estimates of expenditures on vaccine.
Step 2) Calculate the share of national immunization schedule vaccine expenditure funded by domestic govrnment for low- and middle-income WHO Member States (based on the 2019 World Bank classification).
Step 3) Limit analysis to countries that have complete data available from 2018 through the most recent reporting year.
Step 4) Calculate the share of national immunization schedule vaccine expenditure funded by domestic government and round to the nearest whole number.
Step 5) Calculate the percent change in the share calculated in the previous step (e.g., 2018-2019, 2019-2020, etc.).
Step 6) Categorize into Increased, Stable, or Declined based on the percent change (“Stable” is defined as 0% change between the two consecutive years).
ccine expenditures, but expenditures related to doses of vaccine given through supplemental immunization activities (SIAs) are excluded.